These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6427626)

  • 1. Problems in methadone treatment: the influence of reference groups.
    Hunt DE; Lipton DS; Goldsmith DS; Strug DL
    NIDA Res Monogr; 1984; 46():8-22. PubMed ID: 6427626
    [No Abstract]   [Full Text] [Related]  

  • 2. [Social competence evaluated by patients on methadone maintenance treatment program].
    Szczepańskai L; Chrostek Maj J; Jenner B
    Przegl Lek; 2005; 62(6):382-6. PubMed ID: 16225074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Organization and implementation of the Austrian methadone program and initial results].
    Pfersmann D; Presslich O; Pakesch G; Hollerer E; Pfersmann V
    Nervenarzt; 1990 Jul; 61(7):438-43. PubMed ID: 2392186
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limit setting on drug abuse in methadone maintenance patients.
    McCarthy JJ; Borders OT
    Am J Psychiatry; 1985 Dec; 142(12):1419-23. PubMed ID: 4073304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Substance-controlled drug rehabilitation?].
    Rubner O
    Nervenarzt; 1992 Jul; 63(7):447-9. PubMed ID: 1323765
    [No Abstract]   [Full Text] [Related]  

  • 7. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to treatment-related and support services in methadone treatment programs.
    Berkman ND; Wechsberg WM
    J Subst Abuse Treat; 2007 Jan; 32(1):97-104. PubMed ID: 17175403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involving significant others in the care of opioid-dependent patients receiving methadone.
    Kidorf M; King VL; Neufeld K; Stoller KB; Peirce J; Brooner RK
    J Subst Abuse Treat; 2005 Jul; 29(1):19-27. PubMed ID: 15979528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a methadone rehabilitation program.
    Graham-Bafus S; Allen RH; Gordon JR
    Psychol Rep; 1984 Aug; 55(1):99-106. PubMed ID: 6484100
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of outcome in methadone programs: effect of HIV counseling and testing.
    Farley TA; Cartter ML; Wassell JT; Hadler JL
    Conn Med; 1994 Mar; 58(3):165-71. PubMed ID: 8039381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methadone substitution treatment. Results of an evaluation of 3 years implementation in an Austrian province].
    Rittmannsberger H; Ruschak M; Silberbauer C
    Nervenarzt; 1994 May; 65(5):338-44. PubMed ID: 8052337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternative program for methadone maintenance dropouts: description and preliminary data.
    Goldstein MF; Deren S; Beardsley M; Richman BL
    Mt Sinai J Med; 2001 Jan; 68(1):33-40. PubMed ID: 11135504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in the analysis of clinical trials for opiate dependence.
    Follmann D; Wu M; Geller N
    NIDA Res Monogr; 1992; 128():97-113; discussion 114-5. PubMed ID: 1436019
    [No Abstract]   [Full Text] [Related]  

  • 15. [Substitute drug treatments with methadone].
    von Bardeleben U; Stohler R; Petitjean S; Ladewig D
    Ther Umsch; 1993 Mar; 50(3):139-47. PubMed ID: 8475468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of opioid dependence.
    Minovitz O
    CMAJ; 1988 Mar; 138(6):496. PubMed ID: 3345474
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment].
    Fernández Miranda J; González García-Portilla M; Sáiz Martínez P; Gutiérrez Cienfuegos E; Bobes García J
    Actas Esp Psiquiatr; 2001; 29(4):228-32. PubMed ID: 11470057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to improve compliance with narcotic antagonists.
    Kosten TR; Kleber HD
    Am J Drug Alcohol Abuse; 1984; 10(2):249-66. PubMed ID: 6475891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].
    Trémeau F; Darreye A; Leroy B; Renckly V; Ertlé S; Weibel H; Khidichian F; Macher JP
    Encephale; 2003; 29(4 Pt 1):285-92. PubMed ID: 14615698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment.
    Pérez de Los Cobos J; Trujols J; Valderrama JC; Valero S; Puig T
    Drug Alcohol Depend; 2005 Sep; 79(3):405-12. PubMed ID: 15869846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.